MARKET UPDATES CONSUMER 🔸 $BSET: Q1 EPS $0.21 (est. $0.03), rev $82.2M (est. $79.62M). 🔸 $LCID: Q1 production 2,212 vehicles, 600+ in transit; delivered 3,109; files to sell $1B in notes; guides Q1 revs $232M-$236M (est. $256.3M). 🔸 $LYFT: Downgraded to Underperform at BofA, tgt cut to $10.50. 🔸 $NKE, $ADDYY: Shares drop on new 46% Vietnam tariff (impacting AEO, W). 🔸 $RH: Q4 revs $812.4M (est. $829.6M), EPS $1.58 (est. $1.91); guides FY25 rev growth 10%-13%; warns of tariff risks. 🔸 $ROST, $TJX: Upgraded to Buy at Citi; tariffs boost off-price retail inventory. ENERGY, INDUSTRIALS & MATERIALS 🔸 $BALL, $CCK: Potential impact from new 25% tariff on canned beer, aluminum. 🔸 $EMN: Upgraded to Outperform at Mizuho, tgt $105 (+18% upside). 🔸 $LSTR: Q1 EPS cut to $0.90-$0.95 (prior $1.05-$1.25) due to supply chain fraud. 🔸 $MSM: Q2 EPS $0.72 in line, revs $891.72M (est. $908.3M). 🔸 $PCAR: CFO Harrie Schippers to retire; Brice Poplawski promoted. FINANCIALS 🔸 $RGP: Q3 adj. EBITDA $1.7M (est. -$0.5M), revs $129.4M (est. $130M). HEALTHCARE 🔸 $RXST: Cuts FY25 rev view to $160M-$175M (prior $185M-$197M). 🔸 $SRNA: Files for $100M mixed shelf. 🔸 Drugmakers ($AZN, $SNY, $NVO): Spared from Trump tariffs, benefiting exporters. 🔸 Medical Devices ($DXCM, $GHHC, $BSX, $ABT): Under pressure due to new tariffs (34% China, 20% EU). TECH, MEDIA & TELECOM 🔸 $MSFT: Pausing data center projects, impacting VRT, CRWV, ETN, SMCI, DELL, VST, SMR, OKLO, NRG, CEG. 🔸 $GCT: Increases buyback by $16M. 🔸 $PDD: Investing $13B over three years to support merchants. 🔸 $PENG: Q2 EPS $0.52 (est. $0.38), sales $366M (+29% y/y, est. $345.1M).